A phase III multicenter randomized study of atezolizumab

Project: Research project

Project Details

Description

A phase III, multicenter, randomized, study of atezolizumab versus placebo administered in combination with paclitaxel, carboplatin and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal canc
StatusActive
Effective start/end date6/1/175/30/21

Funding

  • Genentech Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.